CUSIP: 45114M109
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,118,276
-
Share change
-
-4,076,701
-
Total reported value
-
$101,490,426
-
Put/Call ratio
-
0%
-
Price per share
-
$3.16
-
Number of holders
-
67
-
Value change
-
-$23,146,758
-
Number of buys
-
33
-
Number of sells
-
25
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 45114M109:
Institutional Holders of ICOSAVAX INC - COM (ICVX) as of Q3 2022
As of 30 Sep 2022,
ICOSAVAX INC - COM (ICVX) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,118,276 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Qiming U.S. Ventures Management, LLC, ADAMS STREET PARTNERS LLC, FMR LLC, T. Rowe Price Investment Management, Inc., PLATINUM INVESTMENT MANAGEMENT LTD, CITADEL ADVISORS LLC, BlackRock Inc., NanoDimension, Inc., and VANGUARD GROUP INC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.